Evidence map›Paper›PMID 28821253›Full record

ArticleBMC complementary and alternative medicine2017

Evidence based anti-osteoporosis effects of Periplaneta americana L on osteoblasts, osteoclasts, vascular endothelial cells and bone marrow derived mesenchymal stem cells.

Yan-Fen Huang, Long-Jian Li, Si-Qian Gao, Yang Chu, Jie Niu, Fu-Neng Geng, Yong-Mei Shen, Li-Hua Peng

Open access · goldAbstract read
In one paragraph

Article in BMC complementary and alternative medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it, 31 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. [Effect of micro RNA-335-5p regulating bone morphogenetic protein 2 on osteogenic differentiation of human bone marrow mesenchymal stem cells].Zhongguo xiu fu chong jian wai ke za zhi = Zhongguo xiufu chongjian waike zazhi = Chinese journal of reparative and reconstructive surgery · 2020
    Article
  11. Frontiers in pharmacology · 2020
    Article
  12. Article
  13. Frontiers in pharmacology · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Yan-Fen HuangInstitute of Pharmaceutics, College of Pharmaceutical Sciences, Zhejiang University, 866# Yuhangtang Road, Hangzhou City, 310058, People's Republic of China.
Long-Jian LiInstitute of Pharmaceutics, College of Pharmaceutical Sciences, Zhejiang University, 866# Yuhangtang Road, Hangzhou City, 310058, People's Republic of China.
Si-Qian GaoInstitute of Pharmaceutics, College of Pharmaceutical Sciences, Zhejiang University, 866# Yuhangtang Road, Hangzhou City, 310058, People's Republic of China.
Yang ChuInstitute of Pharmaceutics, College of Pharmaceutical Sciences, Zhejiang University, 866# Yuhangtang Road, Hangzhou City, 310058, People's Republic of China.
Jie NiuInstitute of Pharmaceutics, College of Pharmaceutical Sciences, Zhejiang University, 866# Yuhangtang Road, Hangzhou City, 310058, People's Republic of China.
Fu-Neng GengSichuan Engineering Research Center for Medicinal Animals, Yingmenkou Road 88#, Chengdu City, Sicuan Province, People's Republic of China.
Yong-Mei ShenGOODDOCTOR Pharmaceutical Company, Yingmenkou Road 88#, Chengdu City, Sicuan Province, People's Republic of China.
Li-Hua PengInstitute of Pharmaceutics, College of Pharmaceutical Sciences, Zhejiang University, 866# Yuhangtang Road, Hangzhou City, 310058, People's Republic of China. lhpeng@zju.edu.cn.
Zhejiang University · CNBuchang Pharma (China) · CNMacau University of Science and Technology · MO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundKangfuxin (KFX) is the ethanol extract of Periplaneta americana L, which has been widely used in the Traditional Chinese Medicine for the repair and regeneration of injured organ and tissues with long history. This study is to investigate the influence of KFX in the various cellular activities and evaluate the anti-osteoporosis potential of KFX.

methodsThe influence of the KFX in the cellular activities, including: 1) migration, osteocalcin secretion of osteoblasts; 2) apoptosis of osteoclasts; 3) migration and tube formation of human umbilical vein endothelial cell (HUVEC); and 4) proliferation, cell cycle regulation and migration of bone marrow mesenchymal stem cells (BMSCs), were investigated systematically.

resultsKFX was shown to significantly 1) Promote of the migration of osteoblasts, HUVEC, and BMSCs; 2) Increase the secretion of osteocalcin and mineralization of osteoblasts; 3) Accelerate the apoptosis of osteoclasts; 4) Stimulate the proliferation and regulate the cell cycle of BMSCs.

conclusionTaken together, these results provide the evidence for the osteogenesis, anti-osteoporosis and angiogenesis effects of KFX, with the mechanism of activating the bone formation through stimulating the osteoblasts and HUVECs, as well as inhibiting the bone absorption by inhibiting the osteoclasts activities. The KFX was definitely shown a promising bone turnover agent with great potential for anti-osteoporosis treatment.

Indexed as

OsteoporosisPeriplanetaAnimalsApoptosisBone Density Conservation AgentsBone MarrowBone Marrow CellsBone ResorptionCell CycleCell MovementCell ProliferationEndothelial CellsEndothelium, VascularHumansHuman Umbilical Vein Endothelial CellsMesenchymal Stem CellsBone Density Conservation AgentsOsteocalcinPlant ExtractsAnti-osteoporosisBMSCsHUVECsOsteoblastsOsteoclastsPeriplaneta americana L

Identifiers

PMID28821253
PMCPMC5563055
OpenAlexW2748619489

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.